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as barotrauma contributes to a significant number of deaths. Adopting this strategy has produced good results in the management of both adults and children with asthma.78 Prolonged endotracheal intubation and invasive vascular monitoring increase the risk of sepsis and barotrauma. Aggressive treatment of asthma to allow early tracheal extubation and removal of intravascular lines may reduce morbidity and mortality. The British Thoracic Society has published guidelines for the management of severe acute asthma in adults9 and our patient was managed according to these guidelines but failed to improve over three days. There are few published data on which to base the management of patients who fail to respond to maximal conventional therapy. The volatile anaesthetic agents are potent bronchodilators and have been used successfully.'1'2 Ether has traditionally been used, its major advantage being that it does not cause hypotension, but it is inflammable and explosive which poses a significant risk to the patient. Halothane, enflurane and isoflurane have all been used and there are no data to support the use of one agent in preference to the others. Isoflurane has a wider therapeutic index and is the agent of first choice in our unit. Our patient failed to respond to prolonged administration of isoflurane and was therefore treated with a ketamine infusion. Ketamine is licensed for use as an intravenous anaesthetic agent but not as a sedative or bronchodilator in intensive care. Previous unlicensed use of anaesthetic agents in intensive care has been associated with increased mortality.'314 We believe that ketamine should only be used when a patient has failed a trial of maximum conventional treatment but our experience suggests that systematic evaluation of its use in resistant status asthmaticus is justified.
